Matrix Capital Management Company LP Has Upped By $17.09 Million Its Seattle Genetics (SGEN) Holding; Clearfield (CLFD) Shorts Increased By 0.11%

December 7, 2017 - By Vivian Currie

Matrix Capital Management Company Lp increased Seattle Genetics Inc (SGEN) stake by 18.79% reported in 2017Q2 SEC filing. Matrix Capital Management Company Lp acquired 335,000 shares as Seattle Genetics

Inc (SGEN)’s stock rose 1.68%. The Matrix Capital Management Company Lp holds 2.12 million shares with $109.59 million value, up from 1.78M last quarter. Seattle Genetics Inc now has $8.20 billion valuation. The stock increased 0.34% or $0.195 during the last trading session, reaching $56.945. About 79,861 shares traded. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since December 7, 2016 and is uptrending. It has outperformed by 58.98% the S&P500.

Clearfield Incorporated (NASDAQ:CLFD) had an increase of 0.11% in short interest. CLFD’s SI was 890,500 shares in December as released by FINRA. Its up 0.11% from 889,500 shares previously. With 32,100 avg volume, 28 days are for Clearfield Incorporated (NASDAQ:CLFD)’s short sellers to cover CLFD’s short positions. The SI to Clearfield Incorporated’s float is 7.71%. It closed at $13.25 lastly. It is down 19.57% since December 7, 2016 and is downtrending. It has underperformed by 36.27% the S&P500.

Among 18 analysts covering Seattle Genetics (NASDAQ:SGEN), 7 have Buy rating, 0 Sell and 11 Hold. Therefore 39% are positive. Seattle Genetics had 56 analyst reports since July 31, 2015 according to SRatingsIntel. Cantor Fitzgerald downgraded the shares of SGEN in report on Wednesday, July 27 to “Hold” rating. The rating was maintained by Oppenheimer with “Hold” on Monday, June 26. As per Monday, October 10, the company rating was maintained by RBC Capital Markets. The stock has “Hold” rating by Cantor Fitzgerald on Wednesday, August 16. On Friday, October 30 the stock rating was upgraded by Piper Jaffray to “Neutral”. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) earned “Hold” rating by Oppenheimer on Wednesday, August 16. The rating was initiated by Oppenheimer on Wednesday, November 8 with “Hold”. Piper Jaffray maintained it with “Hold” rating and $55.0 target in Friday, October 27 report. On Thursday, February 4 the stock rating was initiated by Barclays Capital with “Overweight”. Guggenheim initiated the shares of SGEN in report on Monday, October 23 with “Buy” rating.

Investors sentiment decreased to 1.3 in Q2 2017. Its down 0.20, from 1.5 in 2017Q1. It is negative, as 30 investors sold SGEN shares while 75 reduced holdings. 48 funds opened positions while 89 raised stakes. 137.48 million shares or 0.82% less from 138.62 million shares in 2017Q1 were reported. Amalgamated Bank & Trust has 0.03% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 17,808 shares. Drw Securities Ltd Liability Corp holds 0.04% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN) for 4,000 shares. Wexford Capital Limited Partnership owns 24,100 shares for 0.09% of their portfolio. Peak6 LP reported 6,518 shares. Washington-based Cornerstone Advisors has invested 0% in Seattle Genetics, Inc. (NASDAQ:SGEN). Strs Ohio holds 1,235 shares or 0% of its portfolio. Swiss Bancorporation reported 0.02% in Seattle Genetics, Inc. (NASDAQ:SGEN). Ny State Common Retirement Fund reported 261,358 shares. National Bank Of Montreal Can stated it has 0% in Seattle Genetics, Inc. (NASDAQ:SGEN). British Columbia Invest Mngmt owns 48,557 shares. Metropolitan Life Insurance Ny has invested 0% in Seattle Genetics, Inc. (NASDAQ:SGEN). Winfield Associates has invested 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Tradewinds Cap Mngmt Limited Com, a Washington-based fund reported 2,344 shares. Qs Limited Co holds 0% or 3,511 shares. Assetmark reported 193 shares.

Among 2 analysts covering Clearfield (NASDAQ:CLFD), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Clearfield had 5 analyst reports since August 20, 2015 according to SRatingsIntel. Northland Capital maintained Clearfield, Inc. (NASDAQ:CLFD) rating on Monday, October 16. Northland Capital has “Buy” rating and $15.0 target. On Friday, July 28 the stock rating was maintained by Northland Capital with “Buy”. On Thursday, August 20 the stock rating was upgraded by Zacks to “Hold”. As per Monday, November 23, the company rating was initiated by Lake Street. Northland Capital initiated the stock with “Outperform” rating in Thursday, October 1 report.

Clearfield, Inc. manufactures, markets, and sells standard and custom passive connectivity products to the fiber-to-the-premises , large enterprises, and original equipment manufacturers markets in the United States. The company has market cap of $183.00 million. The firm offers Clearview cassette, a main building block of the companyÂ’s product platform; Clearview Classic and Clearview Blue, a system with five parts that nest together in the cassetteÂ’s main housing to support a range of applications; Clearview xPAK to land small port count fiber terminations and optical components; and fiber deep for cable-to-cable deployment, as well as packages optical components for signal coupling, splitting, termination, multiplexing, demultiplexing, and attenuation for integration within its fiber management platform. It has a 47.32 P/E ratio. The Company’s products also include Fieldsmart Fiber Crossover Distribution System and FieldSmart FxHD for fiber management modularity and scalability; FieldSmart Fiber Scalability Center, a modular and scalable outside plant cabinet that allows rollout of FTTP services; FieldSmart Fiber Delivery Point, a series of enclosure systems that incorporates the delivery of fiber connectivity to the neighborhood or business district; and FieldSmart Small Count Delivery, an enclosure systems that are packaged to make landing small count fiber cost-effective and efficient.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>